Tag: T2 Biosystems

September 25, 2019

T2 Biosystems to Expand into Puerto Rico and US Virgin Islands

The company will expand its rapid diagnostic technologies such as T2Bacteria and T2Candida Panels into Puerto Rico and the US...
September 11, 2019

T2 Biosystems Receives Funding from BARDA

T2 Biosystems (NASDAQ:TTOO) has announced it has been awarded a contract worth US$6 million with a potential valuation of up...
August 16, 2019

T2 Biosystems Expands Rapid Diagnostic Technologies to Australia, Fiji and New Zealand

T2 Biosystems (NASDAQ:TTOO) has announced it has expanded its diagnostic technologies, including T2Bacteria and T2Candida Panels, to Australia, Fiji and...
September 26, 2018

New Data Suggests T2 Biosystems’ T2Lyme Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease

T2 Biosystems (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in...
March 7, 2018

T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update

T2 Biosystems, (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs...
February 9, 2018

Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing

T2 Biosystems (NASDAQ:TTOO), a leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, is...
January 5, 2017

T2 Biosystems, Inc. Announces $50M Credit Facility

T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products that improve patient health and deliver a strong economic return...